Voice Change in End-Stage Renal Disease Patients After Hemodialysis: Correlation of Subjective Hoarseness and Objective Acoustic Parameters

被引:13
|
作者
Jung, Soo Yeon [1 ]
Ryu, Jung-Hwa [2 ]
Park, Hae Sang [1 ]
Chung, Sung Min [1 ]
Ryu, Dong-Ryeol [2 ]
Kim, Han Su [1 ]
机构
[1] Ewha Womans Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul 158710, South Korea
[2] Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul 158710, South Korea
关键词
Acoustic analysis; Hemodialysis; Hoarseness; NOISE RATIO; HARMONICS; DIALYSIS; FATIGUE;
D O I
10.1016/j.jvoice.2013.07.009
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Introduction. Patients with end-stage renal disease (ESRD) who are treated with hemodialysis (HD) frequently complain about hoarseness after completion of each HD session. The HD treatment affects laryngeal volume and muscle function. This study attempted to evaluate the vocal effect of HD by acoustic and aerodynamic analysis and to determine the difference between voice change group (VCG) and nonvoice change group (NVCG). Materials and Methods. A total of 55 patients (34 females and 21 males) diagnosed with ESRD and undergoing outpatient HD were enrolled. The subjects were divided into the VCG (n = 13) and NVCG (n = 42) by the change of the Korean Voice Handicap Index score. Patients underwent weighing and acoustic, aerodynamic analysis before and after the HD. Fundamental frequency (F0), jitter, shimmer, noise-to-harmonics ratio (NHR), pitch range, habitual pitch, voice energy, and maximal phonation time (MPT) were obtained. The pre- and post-HD data were compared using paired t test. The results were compared after dividing the total group into the VCG and NVCG categories. Correlation between the change of the weight and change of the voice analysis result was certified by Pearson correlation coefficient. Results. The F0 and habitual pitch increased in all subjects. The NHR and MPT parameters significantly decreased (P < 0.05). In the NVCG group, all the results were same as the total group. In the VCG group, the NHR result differed from the total group. All acoustic parameters showed no statistically significant differences between the two groups. There was no correlation between the weight change (%) and the change of acoustic parameter results. Conclusions. The NVCG group of patient displayed improvement in NHR, whereas the VCG group showed no change. Weight change did not significantly correlate with the voice analysis results.
引用
收藏
页码:226 / 230
页数:5
相关论文
共 50 条
  • [21] The Evaluation of the Periodontal Status of Hemodialysis Patients with End-Stage Renal Disease
    Dembowska, Elzbieta
    Jaron, Aleksandra
    Raslawska-Socha, Joanna
    Gabrysz-Trybek, Ewa
    Bladowska, Joanna
    Gacek, Szymon
    Trybek, Grzegorz
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [22] Prevalence of diarrhea in end-stage renal disease patients initiating hemodialysis
    Oba, Miho
    Minakuchi, Hitoshi
    Yoshida, Tadashi
    RENAL REPLACEMENT THERAPY, 2021, 7 (01)
  • [23] GASTROINTESTINAL MOTILITY IN PATIENTS WITH END-STAGE RENAL DISEASE ON CHRONIC HEMODIALYSIS
    Broberg, Bo
    Madsen, Jan
    Fuglsang, Stefan
    Holst, Jens
    Christensen, Karl
    Rydahl, Casper
    Idorn, Thomas
    Feldt-Rasmussen, Bo
    Hornum, Mads
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 318 - 318
  • [24] Dialyzer reuse and the treatment of patients with end-stage renal disease by hemodialysis
    Kimmel, PL
    Mishkin, GJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1998, 9 (11): : 2153 - 2156
  • [25] THE PHARMACOKINETICS OF AMINOGUANIDINE IN END-STAGE RENAL-DISEASE PATIENTS ON HEMODIALYSIS
    FOOTE, EF
    LOOK, ZM
    GILES, P
    KEANE, WF
    HALSTENSON, CE
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 420 - 425
  • [26] Dental Care for Patients with End-Stage Renal Disease and Undergoing Hemodialysis
    Costantinides, Fulvia
    Castronovo, Gaetano
    Vettori, Erica
    Frattini, Costanza
    Artero, Mary Louise
    Bevilacqua, Lorenzo
    Berton, Federico
    Nicolin, Vanessa
    Di Lenarda, Roberto
    INTERNATIONAL JOURNAL OF DENTISTRY, 2018, 2018
  • [27] FGF-23 in patients with end-stage renal disease on hemodialysis
    Imanishi, Y
    Nakatsuka, K
    Inaba, M
    Nagasue, K
    Okuno, S
    Miura, M
    Miyauchi, A
    Kobayashi, K
    Ishimura, E
    Nishizawa, Y
    BONE, 2003, 32 (05) : S116 - S116
  • [28] PHARMACOKINETICS AND PHARMACODYNAMICS OF EVOGLIPTIN IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS
    Kim, B.
    Yu, K.
    Lee, S.
    Oh, J.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S67 - S67
  • [29] Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis
    Teigen, Mette Maja B.
    Duffull, Stephen
    Dang, Lily
    Johnson, David W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1259 - 1267
  • [30] Survival of patients with AIDS and end-stage renal disease receiving hemodialysis
    Ifudu, O
    Salifu, MO
    Reydel, C
    DiRienzo, R
    McClendon, E
    Bley, A
    Waltrous, C
    Oguagha, C
    Friedman, EA
    DIALYSIS & TRANSPLANTATION, 2004, 33 (04) : 176 - +